GPCM
ADMS
Granite Point Capital Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Hold |
0
| – | – | – | 112 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 100 |
|
|
2019
Q3 | – | Sell |
-54,822
| Closed | -$340K | – | 93 |
|
|
2019
Q2 | $340K | Hold |
54,822
| – | – | 0.02% | 61 |
|
|
2019
Q1 | $390K | Hold |
54,822
| – | – | 0.04% | 73 |
|
|
2018
Q4 | $468K | Sell |
54,822
-139,893
| -72% | -$1.19M | 0.09% | 58 |
|
|
2018
Q3 | $3.9M | Sell |
194,715
-7,400
| -4% | -$148K | 0.26% | 12 |
|
|
2018
Q2 | $5.22M | Sell |
202,115
-40,800
| -17% | -$1.05M | 0.47% | 9 |
|
|
2018
Q1 | $5.81M | Sell |
242,915
-27,600
| -10% | -$660K | 0.56% | 5 |
|
|
2017
Q4 | $9.17M | Sell |
270,515
-63,000
| -19% | -$2.14M | 0.9% | 3 |
|
|
2017
Q3 | $7.06M | Buy |
333,515
+70,000
| +27% | +$1.48M | 1.49% | 4 |
|
|
2017
Q2 | $4.61M | Buy |
263,515
+28,000
| +12% | +$490K | 1.14% | 7 |
|
|
2017
Q1 | $4.12M | Sell |
235,515
-20,516
| -8% | -$359K | 1.23% | 4 |
|
|
2016
Q4 | $4.33M | Buy |
256,031
+31,700
| +14% | +$536K | 3.45% | 5 |
|
|
2016
Q3 | $3.68M | Hold |
224,331
| – | – | 1.44% | 11 |
|
|
2016
Q2 | $3.4M | Buy |
+224,331
| New | +$3.4M | 1.46% | 8 |
|
|
2015
Q4 | $2.85M | Buy |
100,631
+45,000
| +81% | +$1.27M | 0.43% | 10 |
|
|
2015
Q3 | $931K | Sell |
55,631
-6,182
| -10% | -$103K | 0.64% | 38 |
|
|
2015
Q2 | $1.62M | Hold |
61,813
| – | – | 0.47% | 27 |
|
|
2015
Q1 | $1.08M | Hold |
61,813
| – | – | 0.39% | 41 |
|
|
2014
Q4 | $1.07M | Hold |
61,813
| – | – | 0.5% | 38 |
|
|
2014
Q3 | $1.04M | Buy |
+61,813
| New | +$1.04M | 0.52% | 36 |
|